Pipeline

Application
Discovery
Preclinical
Phase 1

ONCOLOGY

T Cell Directed Oncology

CD20 x CD3

NHL and Other B Cell Proliferative Diseases

Agonist Oncology

Death Receptor 5

Solid Tumors

Immuno-oncology Receptor

All Tumors

Immune Checkpoints

PD-L1

All Tumors

PD-L1 x CTLA-4

All Tumors

INFECTIOUS DISEASES

GP120 x CD3

HIV Treatment/Cure

Target A x CD3

HBV Treatment/Cure